http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2010000447-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
filingDate 2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e6fd5fa94c327d7c97d75e66704fbe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b64625dcf0f10afa442162dbe774e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9f36d7b94dba98bb1216cc4cd6e750
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59e20f59d2f0a597ceea2f2d21d51d57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ccb7a94bc94271916c58a0c49bb33a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68dddfd23c58c9e09bd17d8a7ab4b0e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfb2ec42b98106b54c708d8399a3b3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba9997e9c23130529e61dcc721048262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47f0fdbc4a56688e145009eb57f30bf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ddec790cfa3c5a83bd15d4767fd4574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c1aa9d737b78decdd2a944cd765ea0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94d1fa77924e9908f1624fbc3ec29346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dacc3c3159b5ddd6235dd86913b5b7a8
publicationDate 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2010000447-A1
titleOfInvention Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
abstract The present invention provides compounds of formula (la), pharmaceutical compositions thereof, and methods of using the same in the treatment or prevention of diseases mediated by the activation of 3-adrenoceptor.
priorityDate 2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420320392
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID155
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25645
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464113
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID699129
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID442979
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID430991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2331391

Total number of triples: 39.